Kanya Rajangam
Chief Tech/Sci/R&D Officer presso SENTI BIOSCIENCES, INC.
Patrimonio netto: 38 077 $ in data 31/03/2024
Profilo
Kanya Rajangam is an Independent Director at Turnstone Biologics, Inc. since 2011, an Independent Director at Turnstone Biologics Corp.
since 2021, and the Chief Medical & Development Officer at Senti Biosciences, Inc. since 2022.
Previously, Dr. Rajangam held positions such as Executive Director at Nektar Therapeutics in 2015, Senior Medical Director at Onyx Pharmaceuticals, Inc. from 2011 to 2015, and Associate Medical Director at Exelixis, Inc. from 2008 to 2011.
Dr. Rajangam also served as the Chief Medical Officer at Cleave Therapeutics, Inc. from 2016 to 2017, Chief Medical Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2017 to 2018, and Chief Medical Officer at Nkarta, Inc. from 2019 to 2022.
Dr. Rajangam holds a doctorate degree from Northwestern University (2006) and St. John's Medical College (1996).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SENTI BIOSCIENCES, INC.
0.22% | 01/02/2024 | 101 000 ( 0.22% ) | 38 077 $ | 31/03/2024 |
| 16/10/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Kanya Rajangam
| Società | Posizione | Inizio |
|---|---|---|
| SENTI BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01/07/2022 |
| TURNSTONE BIOLOGICS CORP. | Director/Board Member | 01/11/2021 |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Director/Board Member | 01/11/2011 |
Precedenti posizioni note di Kanya Rajangam
| Società | Posizione | Fine |
|---|---|---|
| NKARTA, INC. | Chief Tech/Sci/R&D Officer | 05/06/2022 |
| ATARA BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/09/2018 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/07/2017 |
| NEKTAR THERAPEUTICS | Director/Board Member | 01/05/2015 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Chief Tech/Sci/R&D Officer | 01/02/2015 |
Formazione di Kanya Rajangam
| Northwestern University | Doctorate Degree |
| St. John's Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| EXELIXIS, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Health Technology |
- Borsa valori
- Insiders
- Kanya Rajangam
